demonstrated that VTN expression was highest in metastatic prostate cancer, followed by primary prostate cancer tissue and benign prostatic hyperplasia tissue, suggesting its association with prostate cancer progression and metastasis (12). This evidence concerns the gene VTN and prostate carcinoma.